Apellis Pharmaceuticals (NASDAQ:APLS) announced a new agreement with Sobi (SWOBF) (OTCPK:SWOBY) involving a capped royalty purchase related to Aspaveli (systemic pegcetacoplan), its blood disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback